Typhoid fever: Narrowing therapeutic options in India

Malini R. Capoor, Deepthi Nair, Azra S. Hasan, Pushpa Aggarwal, B. Gupta

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Abstract

Typhoid fever remains an important public health problem in India. One thousand four hundred fifty-eight blood cultures were screened, 178 grew out Salmonella enterica serovar Typhi. On agar dilution minimum inhibitory concentration (MIC) testing, 0.6% of the isolates were resistant to ciprofloxacin, 2% to cefotaxime and 1% to cefepime. Nalidixic acid resistance was observed in 51% isolates, of which 98.9% had decreased susceptibility (MIC> or= 0.125-4 μg/ml) to ciprofloxacin. One strain of nalidixic acid sensitive S. Typhi (NASST) also had a decreased MIC (0.125 μg/ml) to ciprofloxacin. Resistance to third and fourth generation cephalosporins is emerging in India and will gain significance in the coming decade. The molecular basis of resistance to cephalosporins and ciprofloxacin resistance in NASST strains need to be further evaluated for S. Typhi.

Original languageEnglish (US)
Pages (from-to)1170-1174
Number of pages5
JournalSoutheast Asian Journal of Tropical Medicine and Public Health
Volume37
Issue number6
StatePublished - Nov 2006
Externally publishedYes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Typhoid fever: Narrowing therapeutic options in India'. Together they form a unique fingerprint.

Cite this